Science

Joaquim Bellmunt: Predicting immunotherapy response of advanced bladder cancer through a meta-analysis of six independent cohorts

Hospital del Mar/X

Feb 25, 2025, 08:46

Joaquim Bellmunt: Predicting immunotherapy response of advanced bladder cancer through a meta-analysis of six independent cohorts

Joaquim Bellmunt, Medical oncologist at Harvard Medical School, shared a post on X about a paper he co-authored with colleagues published in Nature Communications:

“Our paper ‘Predicting immunotherapy response of advanced bladder cancer through a meta-analysis of six independent cohorts’ is out today at Nature Communications. Data of 707 advanced bladder cancer pts treated with anti-PD-1/anti-PD-L1 to build highly accurate predictive models.”

“Predicting immunotherapy response of advanced bladder cancer through a meta-analysis of six independent cohorts”

Authors: Lilian Marie Boll, Sergio Vázquez Montes de Oca, Marta Camarena, Robert Castelo, Joaquim Bellmunt, Júlia Perera-Bel, Mar Albà.

More posts featuring Joaquim Bellmunt.

advanced bladder cancer cancer immunotherapy Joaquim Bellmunt Júlia Perera-Bel Lilian Marie Boll Mar Albà Marta Camarena OncoDaily Oncology Robert Castelo Sergio Vázquez Montes de Oca

KIMMTRAK (Tebentafusp) uses in Cancer: Dosages, Indications, Expectations and more

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC